Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar Hugerat (30.20) Submitted: 12/31/2012 9:10:16 AM : Underperform Start Price: $25.63 QCOR Score: -227.30

Just another company run by con men and plagued with nepotism.

Featured Broker Partners


Advertisement